Revolution Medicines Inc

Revolution Medicines Inc

RVMD

Market Cap$7.27B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Revolution Medicines IncRevolution Medicines Inc-10.9--25%-0.1
$71.00

Target Price by Analysts

81.5% upsideRevolution Medicines Target Price DetailsTarget Price
$2.43

Current Fair Value

93.8% downside

Overvalued by 93.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$7.27 Billion
Enterprise Value$6.87 Billion
Dividend Yield$0 (0%)
Earnings per Share$-3.58
Beta1.46
Outstanding Shares167,737,672

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.93
PEG-24.78
Price to Sales-
Price to Book Ratio3.01
Enterprise Value to Revenue9252.96
Enterprise Value to EBIT-10.47
Enterprise Value to Net Income-13
Total Debt to Enterprise0.02
Debt to Equity0.06

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Revolution Medicines Inc

CEO: Mark Goldsmith